Anticoagulation in Patients with Liver Cirrhosis (Literature Review)
Liver cirrhosis is accompanied by complex hemostatic disorders with an increase in the risk of both hemorrhagic and thrombotic complications. Reduced coagulation protein synthesis, such as factors II, VII, IX, X and thrombocytopenia are associated with an increased risk of bleeding. Reducing the syn...
Main Author: | E. S. Eniseeva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Scientific Сentre for Family Health and Human Reproduction Problems
2019-05-01
|
Series: | Acta Biomedica Scientifica |
Subjects: | |
Online Access: | https://www.actabiomedica.ru/jour/article/view/2041 |
Similar Items
-
Anticoagulation in Patients with Liver Cirrhosis
by: Jae Youn Cheong
Published: (2017-11-01) -
Hypercoagulation syndrome at liver cirrhosis
by: I. A. Kurkina, et al.
Published: (2014-12-01) -
The Effect of Anticoagulant in Patients with Cirrhosis Associated with Acute Portal Vein Thrombosis
by: Hoon Gil Jo, et al.
Published: (2021-09-01) -
Safety, efficacy and prognosis of anticoagulant therapy for portal vein thrombosis in cirrhosis: a retrospective cohort study
by: Zhiqi Zhang, et al.
Published: (2023-01-01) -
Non-Malignant Portal Vein Thrombosis in Liver Cirrhosis: Diagnosis and Treatment
by: Tomás Artaza, et al.
Published: (2016-05-01)